Evidence map›Paper›PMID 30661231›Full record

ReviewNeurochemical research2019

Multi-targeted Effect of Nicotinamide Mononucleotide on Brain Bioenergetic Metabolism.

Nina Klimova, Tibor Kristian

Abstract readReview
PubMed Publisher
In one paragraph

Review in Neurochemical research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. PARP1 and OGG1 in Medicated Patients With Depression and the Response to ECT.The international journal of neuropsychopharmacology · 2023
    Article
  12. Article
  13. Review
  14. NADAnimal nutrition (Zhongguo xu mu shou yi xue hui) · 2022
    Review
  15. Article
  16. Article
  17. Review
  18. New Insights for nicotinamide: Metabolic disease, autophagy, and mTOR.Frontiers in bioscience (Landmark edition) · 2020
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Nina KlimovaDepartment of Anesthesiology, Center for Shock, Trauma and Anesthesiology Research, School of Medicine, University of Maryland, 685 West Baltimore Street, MSTF 534, Baltimore, MD, 21201, USA.
Tibor KristianVeterans Affairs Maryland Health Care System, 10 North Greene Street, Baltimore, MD, 21201, USA. tkristian@som.umaryland.edu.ORCID http://orcid.org/0000-0002-1804-8999
University of Maryland, Baltimore · US

Funding

BLRD VA I01 BX000917U.S. Department of Veterans Affairs BX000917
6 · The paper itself

Abstract

Dysfunctions in NAD

Indexed as

AnimalsBrainHumansHydrolasesMitochondriaNADNeurodegenerative DiseasesNiacinamideNicotinamide MononucleotideHydrolasesNADNAD degrading enzymeNiacinamideNicotinamide MononucleotideAcetylationBrainMitochondriaNicotinamide adenine dinucleotideNicotinamide mononucleotide

Identifiers

PMID30661231
OpenAlexW2909055944

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.